Trials / Completed
CompletedNCT03566316
Efficacy/Safety of Telmisartan/Amlodipine/Rosuvastatin in Hypertensive Patients With Hyperlipidemia
Randomized, Double-blind, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine and Rosuvastatin Co-administration in Hypertensive Patients With Hyperlipidemia
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 134 (actual)
- Sponsor
- IlDong Pharmaceutical Co Ltd · Industry
- Sex
- All
- Age
- 19 Years
- Healthy volunteers
- Not accepted
Summary
A Randomized, Double-blind, Multi-center Phase III Clinical Trial to Evaluate the Efficacy and Safety of Telmisartan/Amlodipine and Rosuvastatin Co-administration in Hypertensive Patients with Hyperlipidemia
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Telmisartan/Amlodipine | |
| DRUG | Rosuvastatin | |
| DRUG | Telmisartan |
Timeline
- Start date
- 2015-11-24
- Primary completion
- 2017-06-16
- Completion
- 2017-06-16
- First posted
- 2018-06-25
- Last updated
- 2018-06-25
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT03566316. Inclusion in this directory is not an endorsement.